The Uromigos Podcast
1) Episode 467: The Uromigos Score for MIBC and Advanced Urothelial Cancer
Matt Galsky joins to discuss the latest iteration of the Uromigos Score in Bladder Cancer. This score quantifies the clinical value of various approaches across several disease states. 30 global exper...Show More
2) Episode 442: The History of ARPI Development in Prostate Cancer
Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner
3) Episode 466: #UromigosLive 2025 - Novel Therapy in mRCC
Brian and Tom tag team moderate this session which covers combination data, VEGF/PD1 bispecifics, microbiome approaches, cellular therapy and enrichment strategies.
4) Episode 465: #UromigosLive 2025 - Adjuvant Therapy in RCC
Tom leads the panel discussion about this evolving space including the RAMPART data and the press release about pembro/belzu.
5) Episode 464: #UromigosLive 2025 - The Evolving Landscape of mHSPC
Brian moderates a panel of Chris Sweeney, Tanya Dorff, Mike Morris, Neeraj Aggarwal and Chuck Ryan as they discus and debate the mHSPC space with many treatment options.
6) Episode 459: #UromigosLive 2025 - Radioligands in Prostate Cancer
Brian leads a discussion of Rana McCay, Chris Sweeney and Michael Morris on the PSMAddition data and the landscape of radioligands in prostate cancer.
7) Episode 458: #UromigosLive 2025 - Mock ODAC
Brian takes the role of the FDA and we conduct a mock ODAC on the CREST and POTOMAC data
8) UromigosLive 2025: Resumen de la sesión sobre cáncer de vejiga metastásico
Hay vida más allá de EV Pembro. Los Dres Durán, Gómez de Liaño y Coca Membribes repasan el estudio de DV-Toripalimab presentado recientemente en ESMO. Más similitudes que diferencias con EV302 aunque ...Show More
9) UromigosLive 2025: Resumen de la sesión sobre cáncer de vejiga músculo-invasivo
Los Dres Duran, Gómez de Liaño y Coca Membribes repasan el escenario perioperatorio en cáncer de vejiga músculo infiltrante. En cisplatino ineldgibles, KN905 es un ensayo transformativo en esta poblac...Show More
10) ウロミーゴズライブ2025: 筋層浸潤膀胱がんセッションの振り返り
IMvigor011試験など最新の臨床データをもとに、ctDNAを用いた周術期治療戦略についての最前線をエキスパートが語ります